• OPEN AN ACCOUNT
Indian Indices
Nifty
25,405.30 -48.10
(-0.19%)
Sensex
83,239.47 -170.22
( -0.20%)
Bank Nifty
56,791.95 -207.25
( -0.36%)
Nifty IT
38,854.30 -24.80
( -0.06%)
Global Indices
Nasdaq
44,498.76 -17.19
(-0.04%)
Dow Jones
6,247.07 28.06
(0.45%)
Hang Seng
39,705.85 -56.63
(-0.14%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.59 -0.04
(-0.04%)
EUR-INR
100.92 0.38
(0.38%)
GBP-INR
117.62 0.20
(0.17%)
JPY-INR
0.60 0.00
(0.46%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
345.7618998
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
19.84
106137.94
EPS(TTM)
Face Value()
Div & Yield %
64.1
1
0.63
 

Oxygenta Pharmaceutical reports standalone net loss of Rs 2.15 crore in the March 2025 quarter
May 31,2025
Net loss of Oxygenta Pharmaceutical reported to Rs 2.15 crore in the quarter ended March 2025 as against net profit of Rs 8.02 crore during the previous quarter ended March 2024. Sales rose 368.91% to Rs 49.47 crore in the quarter ended March 2025 as against Rs 10.55 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 10.30 crore in the year ended March 2025 as against net loss of Rs 3.48 crore during the previous year ended March 2024. Sales rose 175.73% to Rs 109.30 crore in the year ended March 2025 as against Rs 39.64 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales49.4710.55 369 109.3039.64 176
OPM %-3.40-15.26 --9.15-24.47 -
PBDT-3.76-2.19 -72 -10.47-11.25 7
PBT-3.53-2.83 -25 -14.08-13.91 -1
NP-2.158.02 PL -10.30-3.48 -196